FABBRI, Leonardo
 Distribuzione geografica
Continente #
NA - Nord America 6.504
AS - Asia 3.833
EU - Europa 1.788
SA - Sud America 616
Continente sconosciuto - Info sul continente non disponibili 149
AF - Africa 110
OC - Oceania 19
Totale 13.019
Nazione #
US - Stati Uniti d'America 6.326
SG - Singapore 1.357
CN - Cina 987
BR - Brasile 486
VN - Vietnam 440
DE - Germania 323
UA - Ucraina 317
HK - Hong Kong 308
IT - Italia 266
TR - Turchia 210
GB - Regno Unito 181
FI - Finlandia 161
BD - Bangladesh 119
FR - Francia 113
SE - Svezia 112
RU - Federazione Russa 100
JP - Giappone 94
IN - India 77
CA - Canada 71
ID - Indonesia 71
MX - Messico 69
PL - Polonia 48
ZA - Sudafrica 41
AR - Argentina 39
IQ - Iraq 29
AT - Austria 28
ES - Italia 28
NL - Olanda 25
VE - Venezuela 21
EC - Ecuador 20
AU - Australia 18
PK - Pakistan 17
CZ - Repubblica Ceca 16
LT - Lituania 15
MA - Marocco 15
KE - Kenya 14
SA - Arabia Saudita 14
CO - Colombia 13
CL - Cile 12
DZ - Algeria 12
PY - Paraguay 12
JM - Giamaica 11
PH - Filippine 11
MY - Malesia 10
EG - Egitto 9
KR - Corea 9
UZ - Uzbekistan 9
CH - Svizzera 8
JO - Giordania 8
BE - Belgio 7
IL - Israele 6
IR - Iran 6
LB - Libano 6
PE - Perù 6
TN - Tunisia 6
TW - Taiwan 6
AZ - Azerbaigian 5
CR - Costa Rica 5
GT - Guatemala 5
IE - Irlanda 5
KZ - Kazakistan 5
PT - Portogallo 5
RO - Romania 5
RS - Serbia 5
TH - Thailandia 5
AL - Albania 4
DK - Danimarca 4
NI - Nicaragua 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
BB - Barbados 3
BH - Bahrain 3
BO - Bolivia 3
GE - Georgia 3
HN - Honduras 3
NP - Nepal 3
OM - Oman 3
TG - Togo 3
BG - Bulgaria 2
CG - Congo 2
GR - Grecia 2
KG - Kirghizistan 2
LU - Lussemburgo 2
MK - Macedonia 2
QA - Qatar 2
SN - Senegal 2
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CM - Camerun 1
CY - Cipro 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
Totale 12.861
Città #
Singapore 872
Ashburn 713
Fairfield 473
San Jose 441
Woodbridge 437
Santa Clara 344
Beijing 304
Jacksonville 304
Hong Kong 301
Houston 279
Chandler 267
Council Bluffs 262
Ann Arbor 189
Wilmington 177
Cambridge 172
Los Angeles 165
Seattle 159
Ho Chi Minh City 152
Izmir 131
New York 106
Nanjing 99
Hanoi 95
Princeton 92
Tokyo 92
Munich 83
Lauterbourg 79
Dallas 75
Helsinki 75
Buffalo 60
Milan 60
Jakarta 53
Mexico City 51
São Paulo 51
Shanghai 50
Warsaw 43
San Diego 39
Boardman 37
Addison 35
Hefei 35
Tianjin 35
Orem 33
Hebei 31
Nanchang 31
Denver 28
Turku 27
Da Nang 26
Changsha 25
Shenyang 25
Chennai 24
Jiaxing 24
Chicago 23
London 22
Bremen 21
Rio de Janeiro 21
Toronto 21
Vienna 21
Dong Ket 20
Johannesburg 20
Montreal 20
Atlanta 19
Moscow 18
Phoenix 18
San Mateo 18
Brooklyn 17
Frankfurt am Main 17
Norwalk 17
Nuremberg 17
San Francisco 17
Baghdad 16
Haiphong 15
Boston 14
Curitiba 14
Falkenstein 14
Washington 14
Brasília 12
Dearborn 12
Guangzhou 12
Nairobi 12
Poplar 12
Rome 12
Philadelphia 11
Redwood City 11
Ankara 10
Belo Horizonte 10
Brno 10
Campinas 10
Charlotte 10
Ferrara 10
Hangzhou 10
Manchester 10
Ningbo 10
Can Tho 9
Genoa 9
Jinan 9
Krasnodar 9
Mountain View 9
Sydney 9
Taizhou 9
Dhaka 8
Falls Church 8
Totale 8.458
Nome #
Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma 251
CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease 249
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma 239
An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal 238
Association between toluene diisocyanate-induced asthma and DQB1 markers: a possible role for aspartic acid at position 57 237
Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis 217
Three-Year Hospitalization and Mortality in Elderly Smokers with Chronic Obstructive Pulmonary Disease or Chronic Heart Failure 210
CD-4-positive T-lymphocytes infiltrate the bronchial mucosa of patients with Sjogren's syndrome 204
Enfisema polmonare: prospettive di terapia 202
Interleukin-13 and-4 expression in the central airways of smokers with chronic bronchitis 202
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 202
Airway smooth muscle biochemistry and asthma 195
Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC 195
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics 193
The distribution of Neurokinin-1 and Neurokinin-2 receptors in human central airways 192
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study 192
Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation 187
Increased bronchial responsiveness in primary Sjogren's syndrome. A sign of tracheobronchial involvement 186
Asthma progression and mortality: The role of inhaled corticosteroids 183
Helicobacter pylori and chronic bronchitis 182
Inflammatory cells in the bronchial glands of smokers with chronic bronchitis 179
Increased xanthine oxidase activity in broncoalveolar lavage fluid from subject with chronic bronchitis 178
Inhaled corticosteroids in COPD: Friend or foe? 175
Increased bronchial responsiveness in primary and secondary Sjogren's syndrome 172
Vasoactive intestinal peptide receptors in the airways of smokers with chronic bronchitis 172
Anti-inflammatory treatments for asthma: Past, present, future 171
Oxygen radical production of broncho-alveolar lavage fluid (BALF) from subjects with chronic bronchitis. 170
Expression of monocyte chemoattractant protein-1 (MCP-1) and CC chemokine receptor 2 (CCR2B) by purified blood monocytes in smokers with lung cancer. 169
Comparative effectiveness of triple therapy versus dual bronchodilation in COPD 167
Increased oxidant-induced clastogenic activity in bronchoalveolar lavage fluid obtained from subjects with chronic bronchitis. 166
Interleukin-6, but not pentraxin 3, predicts adverse clinical outcomes on short-term prognosis of patients with incipient heart failure 166
Differential expression of heme oxygenase (HO)-1 in macrophages of lung tumour and tumour-free lung tissues 166
Altri problemi di patologia respiratoria 165
Cytoplasmic expression of p21 CIPI/WAF1 is increased in endoalveolar macrophages of smokers. 164
Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal 163
Significant correlation between interleukin-10 expression and progression of non-small cell lung cancer through heme oxygenase 162
Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease 161
Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease 158
Blood eosinophils for the management of COPD patients? 156
Integrin expression on neutrophils and mononuclear cells in blood and induced sputum in stable asthma 155
Current controversies in chronic obstructive pulmonary disease: A report from the global initiative for chronic obstructive lung disease scientific committee 155
Prevention of Chronic Obstructive Pulmonary Disease 152
Inhaled corticosteroid containing combinations and mortality in COPD 149
Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact 149
Production of superoxide radicals by bronchoalveolar lavage fluid obteined from patients with chronic bronchitis 147
Chronic obstructive pulmonary disease in heart failure: prevalence, therapeutic and prognostic implications. 145
Human leukocyyte antigen associations in occupational asthma induced by isocyanates 144
Immunization and challenge with toulene diisocyanate decrease tachykinin and calcitonin gene-related peptide immunoreactivity in guinea pig central airways 144
Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: A post-hoc analysis of the PANTHEON study 144
Xanthine oxidase in broncho-alveolar lavage fluid of subjects with chronic bronchitis. 141
Sonicated serum damages human lymphocyte DNA: a model of free radicals induced cell injury 141
What can we learn from late-onset and occupational asthma? 141
Espression of vasoactive intestinal peptide 1 receptor (VIPR1) in the central airways of smokers 141
Mechanism of occupational asthma 137
Chronic cough in adults 134
Neutrophils and asthma. 129
Severity of airflow limitation is associated with severity of airway inflammation in smokers 129
Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation 128
Substance P and neurokinin-A in induced sputum from patients with chronic obstructive pulmonary disease. 126
COPD is a risk factor for squamous cell histotype in smokers who develop nonsmall cell lung cancer. Eur Resp J 2003; 22 Supp.45: 361s. 126
Management of chronic refractory cough in adults 124
Very low density lipoproteins mediate DNA damage induced by sonicated serum on human lymphocytes. 123
Similarities between mechanism of superoxide production in ultrasuond treated human serum and in BALF from patients with chronic bronchitis 123
Extrafine beclometasone dipropionate/ formoterol fumarate vs double bronchodilation therapy in patients with copd: A historical real-world non-inferiority study 123
Mucin expression in the bronchiolar epithelium of patients with chronic obstructive pulmonary disease. 122
A person-centred clinical approach to the multimorbid patient with COPD 118
Glucocorticoidi 118
CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease 115
Neutrophils and Asthma 115
Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA 115
Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations 114
Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best Practice 108
Guidelines and recommendations for the clinical use of bronchoalveolar lavage in asthma 108
Evaluation by self-monitoring and noninvasive measures 107
HLA class II molecules and asthma induced by toleune diisocyanate 106
Influence of asbestos exposure on heme oxygenase(HO)-1 expression in lung tumour-associated macrophages. 169 (7): A411. 104
Subclinical cardiac dysfunction in moderate to severe chronic obstructive pulmonary disease (COPD) patients 104
Small airway dysfunction: not so silent after all? 101
Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study 99
Inhaled long-acting muscarinic antagonists in asthma - A narrative review 94
Sex differences in asthma control, lung function and exacerbations: the ATLANTIS study 78
Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS 78
Spirometry: A practical lifespan predictor of global health and chronic respiratory and non-respiratory diseases 75
Rate of Decline of FEV1 as Biomarker of Survival? 73
Leveraging Computed Tomography Imaging to Detect Chronic Obstructive Pulmonary Disease and Concomitant Chronic Diseases 72
null 50
null 45
The ROME COPD exacerbation proposal works! Time to move forward 10
Clinical phenotyping of asthma patients with elevated sputum eosinophils and low blood eosinophils: a post-hoc analysis of the multicentre ATLANTIS cohort 4
Totale 13.019
Categoria #
all - tutte 64.426
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.902
Totale 66.328


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022769 0 53 49 61 61 25 25 46 36 55 71 287
2022/2023646 78 16 40 79 115 86 36 59 74 3 41 19
2023/2024391 42 48 20 15 25 54 13 25 15 5 11 118
2024/20251.796 38 59 155 47 238 161 29 61 282 224 272 230
2025/20265.400 568 223 437 662 784 358 642 276 536 554 244 116
2026/2027431 151 280 0 0 0 0 0 0 0 0 0 0
Totale 13.019